INKT

8.0206.85%
MO

Melissa Orilall

Principal Financial Officer

Ms. Melissa Orilall is Principal Financial Officer of MiNK Therapeutics, Inc. from March 13, 2026. She joined Agenus in November 2017 and has served as Vice President, Global Financial Operations at Agenus and through the Amended and Restated Intercompany Services Agreement, MiNK, since March 2026 where she is responsible for overseeing general accounting, month-end and quarterly close procedures and financial planning and analysis. Prior to November 2017, she worked at Whitehead Institute for Biomedical Research where she focused on financial planning and modeling. Her experience also includes several years in corporate banking with portfolio management and operational responsibilities. She holds a Canadian CPA designation and an Honors BAS in Accounting from York University in Toronto.

Positions